| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |